All for Joomla All for Webmasters

Presence of Anti-proteinase 3 Antineutrophil Cytoplasmic Antibodies (Anti-PR3 ANCA) as Serologic Markers in Inflammatory Bowel Disease

Rate this item
(0 votes)

Utility:

The role of anti-PR3 antibodies as a serologic marker in inflammatory bowel disease (IBD) is evaluated. The QUANTA Flash PR3 assay was used to evaluate 142 serum samples obtained at early stages of the disease. Results showed that anti-PR3 ANCA were significantly more prevalent and their titers significantly higher among ulcerative colitis compared with Crohn's disease patients. ROC analysis assessed diagnostic accuracy and the area under the curve was 0.81. QUANTA Flash displayed 52.1 % sensitivity and 97.3 % specificity for ulcerative colitis. Combining anti-PR3 ANCA positivity with IgA ASCA negativity as the diagnostic parameter demonstrated highest diagnostic utility, with a sensitivity and specificity of 47.5 % and 98.2 %, respectively.
Read 191 times

Werfen.com. All rights Reserved. Privacy Policy | Cookies Policy | Terms of Service

No Internet Connection